Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
Safety issue puts daclizumab in doubt for MS
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Dynamic regulatory network controlling TH17 cell differentiation.
Differential effects of fingolimod on B-cell populations in multiple sclerosis.
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
Long-Term Safety and Efficacy Study of BIIB017 (PEGylated Interferon Beta-1a) (ATTAIN)
Testing for urinary tract colonisation before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation.
Decreased microglial activation in MS patients treated with glatiramer acetate.
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
Phase II Cladribine Add-on to Interferon-beta (IFN-b) Therapy in MS Subjecs With Active Disease (ONWARD)
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Teaching NeuroImages: MRI in advanced neuromyelitis optica.
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
Gustatory Dysfunction in Multiple Sclerosis
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in relapsing-Remitting Multiple Sclerosis
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Genetics of multiple sclerosis: swimming in an ocean of data.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.

Pages